Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Heart Failure IV: Classification and Diagnostic Evaluation

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Taking Bold Steps for Meaningful Changes in Transplant Cardiology Fellowship Training.

Clinical transplantation·2026

Same author

Expanding Anatomical Feasibility of CardioMEMS Implantation: A Case Report of Successful Implantation in a Patient With Significant Morbid Obesity.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Same author

At the Edge of Failure: Predicting Hemodynamic Collapse.

The American journal of cardiology·2026

Same author

Diagnosis of rejection following heart transplantation: diving into the future.

Frontiers in transplantation·2026

Same author

Implantation of a Left Ventricular Assist Device With Concomitant Repair of Ascending Aortic Aneurysm.

JACC. Case reports·2025

Same author

Towards an understanding of best practice: The good, the bad and the future of cardiogenic shock teams.

American heart journal·2025

Search research articles

Related Experiment Video

Updated: Sep 23, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

The "Right" Definition for Post-Left Ventricular Assist Device Right Heart Failure: The More We Learn, the Less We

Shelley A Hall^1,2, Hannah Copeland³, Amit Alam^1,2

¹Baylor University Medical Center, Dallas, TX, United States.

Frontiers in Cardiovascular Medicine

|May 13, 2022

Summary

Right heart failure after left ventricular assist device implantation is a significant concern. Evolving definitions aim to improve diagnosis, with the 2020 Mechanical Circulatory Support Academic Research Consortium criteria expected to enhance understanding.

Keywords:

Academic Research Consortium Mechanical Circulatory Support left ventricular assist device (LVAD)proper definition right heart failure (RHF)

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Related Experiment Videos

Last Updated: Sep 23, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Area of Science:

Cardiology
Medical Devices
Clinical Definitions

Background:

Right heart failure (RHF) is a critical complication after left ventricular assist device (LVAD) implantation, impacting patient survival.
Previous definitions of RHF following LVAD have evolved over time to better capture this complex condition.

Purpose of the Study:

To evaluate the impact of the latest definition of right heart failure proposed by the Mechanical Circulatory Support Academic Research Consortium (MCS-ARC) in 2020.
To enhance the recognition and understanding of right heart failure in the context of mechanical circulatory support.

Main Methods:

Review of existing literature and definitions for right heart failure post-LVAD.
Analysis of the proposed 2020 MCS-ARC criteria for right heart failure.

Main Results:

The evolution of RHF definitions reflects a growing effort to accurately diagnose this complication.
The 2020 MCS-ARC definition is anticipated to improve the identification and characterization of RHF.

Conclusions:

The 2020 MCS-ARC definition represents a significant advancement in defining right heart failure after LVAD.
Improved diagnostic criteria are crucial for better patient management and outcomes in LVAD recipients.